Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma

Japanese Journal of Ophthalmology

Volumn 47, Issue 1, 2003, Pages 72-76

  Ozdemir, Murat ^a   Ozdemir, Gokhan ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Carteolol pilocarpine combination therapy; Glaucoma; Latanoprost monotherapy; Medical treatment of glaucoma

Indexed keywords

CARTEOLOL; LATANOPROST; PILOCARPINE; PILOSED;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLAUCOMA; HEADACHE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CARTEOLOL; DOUBLE-BLIND METHOD; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PILOCARPINE; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; SAFETY; VISUAL ACUITY;

EID: 0037269155     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(02)00628-7     Document Type: Article

References (20)

1. Gibson J.M., Rosenthal A.R., Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK. 104:1985;196-203.
2. Passo M.S., Palmer E.A., Van Buskirk E.M. Plasma timolol in glaucoma patients. Ophthalmology. 91:1984;1361-1363.
3. McMahon C.D., Shaffer R.N., Hoskins H.D.et al. Adverse effects experienced by patients taking timolol. Am J Ophthalmol. 88:1979;736-738.
4. Stewart W.C., Cohen J.S., Netland P.A., Weiss H., Nussbaum L.L. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group. Am J Ophthalmol. 124:1997;498-505.
5. Le Jeunne C., Munera Y., Teillet L., Hugues F.C. Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline. Allerg Immunol. 20:1988;267-269.
6. Diggory P., Cassels-Brown A., Fernandez C. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. Age Ageing. 25:1996;424-428.
7. Usitalo R.J., Palkama A. Long-term evaluation of timolol. Acta Ophthalmol. 67:1989;573-581.
8. Calissendorff B., Maren N., Wetrell K.et al. Timolol versus pilocarpine separately or combined with acetazolamide. effects on intraocular pressure Acta Ophthalmol. 58:1980;624-631.
9. Zadok D., Geyer O., Zadok J.et al. Combined timolol and pilocarpine alone and timolol alone in the treatment of glaucoma. Am J Ophthalmol. 117:1994;728-731.
10. Zhang W.Y., Wan Po A.L., Dua H.S., Azuara-Blanco A. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol. 85:2001;983-990.
11. Alm A., Widengård I., Kjellgren D.et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 79:1995;12-16.
12. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening and morning. A comparison with timolol. Ophthalmology 1995;102:1743-1752.
13. Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 1996;103:138-147.
14. 2α analogue, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
15. Nilsson S.E.F., Samuelsson M., Bill A., Stjernschantz J. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F-2-alpha-1-isopropyl ester in the cynomolgus monkey. Exp Eye Res. 48:1989;707-716.
16. Weinreb R.N. Compliance with medical treatments of glaucoma. J Glaucoma. 1:1992;134-136.
17. Watson P., Stjernschantz J., Beck L.et al. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 103:1996;126-137.
18. Bucci M.G. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol. a randomized, observer-masked multicenter study in patients with open-angle glaucoma Italian Latanoprost Study Group. J Glaucoma. 8:1999;24-30.
19. Nordmann JP, Söderström M, Rouland JF, Malecaze F, the French Latanoprost Study Group, the Swedish Latanoprost Study Group. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with adrenergic antagonists. Br J Ophthalmol 2000;84:181-185.
20. Scoville B., Krieglstein G.K., Then E.et al. Measuring drug-induced eye irritation. a simple new clinical assay J Clin Pharmacol. 25:1985;210-218.